Skip to main content

Russia Covid-19 vaccine: More than 1 billion people will get Sputnik-V in 2020-21

By Unknown

Amid the race to produce a potential vaccine for the novel coronavirus, Russia today announced that it will be able to vaccinate more than one billion people within 2020-2021, according to a report.

The country's sovereign wealth fund said that more than one billion people would receive its COVID-19 vaccine "Sputnik-V" in the said period, reported Reuters citing the Interfax news agency.

The Russian Direct Investment Fund (RDIF) has already signed a deal to export the vaccine abroad and on the Brazilian state of Bahia. Along with that, the state also aims to buy 50 million doses to market in Brazil, officials said.

Another agreement with Kazakhstan, which is set to buy more than 2 million doses initially and could later increase the volume to 5 million doses.

India will be producing 300 million doses of the vaccine, according to reports.

The update comes in the backdrop of Russia earlier announcing that it has successfully fast-tracked its recently launched Sputnik V vaccine and is most likely to release the vaccine for civilian use soon, according to a report.

Sputnik V Covid vaccine, which is developed by Gamaleya Research Institute of Epidemiology and Microbiology under the Russian Health Ministry, may be granted permission to release a batch of its vaccine for civilian use, the institute’s deputy director for research, said associate member of the Russian Academy of Sciences, Denis Logunov, according to a report.

A Phase III trial is a large-scale one involving thousands of people - in Russia, 40,000 - over a longer stretch of time.

Meanwhile, Russian children have returned to schools after attending classes online since the coronavirus pandemic swept the country in late March.

To prevent another spike in cases, all teachers underwent mandatory virus tests before primary and secondary schools re-opened on 1 September. Temperature checks are conducted each morning and and school schedules were amended to reduce the number of students attending at the same time.

Authorities also limited how many children can be together in school cafeterias and recreation areas is also limited.

Moreover, three Moscow outpatient clinics have received the first batch of a covid vaccine against the coronavirus for post-registration trials, news agency TASS reported, citing Deputy Moscow Mayor Anastasia Rakova. Moscow residents can apply to participate in the study and be the first to obtain the vaccine, the deputy mayor said.

On August 11, Russia became the first country to license a Covid-19 vaccine, calling it "Sputnik V" in homage to the world's first satellite, launched by the Soviet Union. But western experts have warned against its use until all internationally approved testing and regulatory steps have been taken. The vaccine is undergoing Phase 3 trials.

The vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal earlier that were hailed by Moscow as an answer to its critics.

The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.


Comments

Post a Comment

Popular posts from this blog

Iran, Russia Discussing Joint Production Of COVID-19 Vaccine

By Unknown
Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday. "We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying. Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil.
Post a Comment
Read more

Increased risks of drop out for women and girls : CoronaVirus Updates

By Unknown
The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...
Post a Comment
Read more

Russia's Covid-19 vaccine Sputnik V available to public now: State media

By Unknown
First batches of Russia's Covid vaccine Sputnik V have entered "civil circulation" in capital Moscow, state media reported on Thursday. While details on the process were not immediately available, Russia has repeatedly stressed on producing the vaccine at the earliest, a belief met with international scepticism. Earlier this month, the Russian health ministry had said that batches of the Covid-19 vaccine were being produced for public distribution and would be supplied to different regions soon. "The first batch of the vaccine for preventing the novel coronavirus infection, Gam-COVID-Vac (Sputnik V) developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Health Ministry passed the required quality tests in the laboratories of Roszdravnadzor (the Federal Service for Surveillance in Healthcare) and was produced for civilian circulation. In the near future the supplies of the first batches of the vaccine to the regions are expected...
Post a Comment
Read more